Coldpine

NVO Congressional Stock Trades

Novo Nordisk A/S Common Stock (NVO)

Last disclosed trade Oct 15

Every disclosed trade in NVO by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Coldpine’s read

The one-day disclosure lag is unusually fast, making this purchase recent and potentially actionable relative to typical filing delays. Greene holds no committee assignments directly tied to pharmaceuticals, suggesting the trade reflects sector interest rather than informational positioning. At least one other member made a same-direction trade in NVO within 30 days, indicating modest cluster interest in the weight-loss drugmaker.

Marjorie Taylor Greene · Bought · Aug 19

Coldpine scores and writes a rationale for every congressional trade. See the full scored analysis with Pro →

Follow $NVO

Get notified when any member of Congress trades $NVO. Free, no card, no spam.

Follow free →
37
Disclosed trades
26
Buys
11
Sells
7
Members trading

Members who trade NVO

Recent disclosed trades in NVO

DateMemberTypeAmount
Oct 15Marjorie Taylor Greene(GA)buy$1K–$15K
Sep 11Lisa McClain(MI)buy$1K–$15K
Aug 28Marjorie Taylor Greene(GA)buy$1K–$15K
Aug 19Marjorie Taylor Greene(GA)buy$15K–$50K
Aug 4Scott Franklin(FL)buy$1K–$15K
Aug 4Scott Franklin(FL)buy$1K–$15K
Aug 4Scott Franklin(FL)buy$1K–$15K
Aug 4Scott Franklin(FL)buy$15K–$50K
May 8Laurel Lee(FL)sell$1K–$15K
Mar 27Scott Franklin(FL)buy$15K–$50K
Mar 27Scott Franklin(FL)buy$1K–$15K
Mar 20Byron Donalds(FL)sell$1K–$15K
Mar 20Byron Donalds(FL)sell$1K–$15K
Dec 23Michael T. McCaul(TX)buy$15K–$50K
Dec 23Michael T. McCaul(TX)buy$15K–$50K
Oct 31Michael T. McCaul(TX)buy$15K–$50K
Oct 31Michael T. McCaul(TX)buy$1K–$15K
Aug 26Michael T. McCaul(TX)sell$1K–$15K
Aug 26Michael T. McCaul(TX)sell$1K–$15K
Aug 9Michael T. McCaul(TX)buy$15K–$50K

Showing 20 of 37 disclosed trades.

Sign up free for the full history, signal scores, and price-vs-trades chart. Pro adds Coldpine's read — the AI narrative on each trade.

Create a free account

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores — free with an account →